Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency

Nat Commun. 2023 Feb 6;14(1):434. doi: 10.1038/s41467-023-35898-2.

Abstract

Gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV), are DNA viruses that are globally associated with human cancers and establish lifelong latency in the human population. Detection of gammaherpesviral infection by the cGAS-STING innate immune DNA-sensing pathway is critical for suppressing viral reactivation from latency, a process that promotes viral pathogenesis and transmission. We report that barrier-to-autointegration factor 1 (BAF)-mediated suppression of the cGAS-STING signaling pathway is necessary for reactivation of KSHV and EBV. We demonstrate a role for BAF in destabilizing cGAS expression and show that inhibiting BAF expression in latently infected, reactivating, or uninfected cells leads to increased type I interferon-mediated antiviral responses and decreased viral replication. Furthermore, BAF overexpression resulted in decreased cGAS expression at the protein level. These results establish BAF as a key regulator of the lifecycle of gammaherpesviruses and a potential target for treating viral infections and malignancies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Epstein-Barr Virus Infections*
  • Gammaherpesvirinae* / genetics
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 8, Human* / genetics
  • Humans
  • Nucleotidyltransferases
  • Virus Latency / genetics
  • Virus Replication

Substances

  • Nucleotidyltransferases
  • BANF1 protein, human